Hepatitis C Information Central


Discover the latest news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information

News, Updates and Commentary

Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

77 more hepatitis cases may trace to clinic, officials say
LAS VEGAS -- Seventy-seven more people that were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said. Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist

77 more hepatitis cases may trace to clinic at center of Las Vegas outbreak, officials say
AM LAS VEGAS-Seventy-seven more people that were treated at a Las Vegas outpatient clinic accused of reusing syringes on thousands of people have been diagnosed with Hepatitis C, health officials said. Authorities cannot say for sure how the 77 people

77 more hepatitis cases may trace to clinic, officials say
Seventy-seven more people that were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said.Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist with the


UPDATES AND COMMENTARY RSS Feed

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...

Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...

Hepatitis C Complications Helped by Maintenance Interferon
A four-year study confirms that low-dosage maintenance interferon therapy prevents disease progression in those with portal hypertension or cirrhosis from Hepatitis C....

All information provided is owned by Hepatitis Central unless otherwise stated.

All material on this server is protected by U.S. and international copyrights. Personal use of material is permitted for research, scientific and/or information purposes only. No part of any material posted on Hepatitis Central website may be copied, downloaded, stored in a retrieval system, or redistributed for any other purpose without the expressed written permission of Hepatitis Central. You may not modify or create derivative works based on Hepatitis Central material.

Every effort has been made by the authors, and contributors, to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, Hepatitis Central will be pleased to make the necessary and reasonable arrangements at the first opportunity.

Requests for permission to use copyrighted material may be emailed to Hepatitis Central.

Linking to the Hepatitis Central web site:

Hepatitis Central has no objection to links made from other sites to the Hepatitis Central site provided that you comply with the following requirements:

You may not frame or alter the appearance of the Hepatitis Central site.
You may not state or imply that the Hepatitis Central endorses, sponsors, or otherwise approves your site or any other site.
You may not use any Hepatitis Central trademarks or logos without prior written consent from Hepatitis Central. The only permitted form of link is a text link on the Hepatitis Central name.

Please see the sample below:

Read the article at the Hepatitis Central site.

In view of the dynamic nature of the Internet, and the possibility of updates and changes, we request that your link enter the Hepatitis Central site at the home page. If you do link to an internal page, we cannot guarantee that the link will remain active. You must abide by all of the other Hepatitis Central, terms and conditions of use. For example, you may not reproduce or host Hepatitis Central content on your web site.

Export Controls

Your use of the Hepatitis Central site will comply with all applicable laws, rules, and regulations that govern the export of technical data.

© Copyright 1994-present Hepatitis Central. All rights reserved. Republication or redistribution of the contents of my site, including by framing or similar means, is expressly prohibited without the prior written consent of Hepatitis Central. Hepatitis Central shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Hepatitis Central retains all proprietary rights to information that is on these pages. By accessing and/or downloading this file, you expressly agree and consent to the foregoing terms and conditions.

Table of Contents

© Hepatitis Central

©1994-Present

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 09 May 2008